Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)

Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)

BACKGROUND-: Hypertension treatment guidelines recommend that blood pressure (BP) be lowered to <140/90 mm Hg, but that a reduction to <130/80 mm Hg be adopted in patients at high cardiovascular (CV) risk. We investigated the CV and renal benefits associated with these BP targets in the high-C...

Full description

Bibliographic Details
Published in:Circulation
Main Author: Mancia G.; Schumacher H.; Redon J.; Verdecchia P.; Schmieder R.; Jennings G.; Yusoff K.; Ryden L.; Liu G.L.; Teo K.; Sleight P.; Yusuf S.
Format: Article
Language:English
Published: 2011
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054959783&doi=10.1161%2fCIRCULATIONAHA.110.008870&partnerID=40&md5=f989306e751fbfbe4334b5f28c48dc69

Similar Items

Similar Items